- /
- Supported exchanges
- / US
- / DSRLF.PINK
DiaSorin S.p.A (DSRLF PINK) stock market data APIs
DiaSorin S.p.A Financial Data Overview
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get DiaSorin S.p.A data using free add-ons & libraries
Get DiaSorin S.p.A Fundamental Data
DiaSorin S.p.A Fundamental data includes:
- Net Revenue: 1 195 M
- EBITDA: 370 M
- Earnings Per Share: 3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-08
- EPS/Forecast: 0.85
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DiaSorin S.p.A News
New
Is DiaSorin (BIT:DIA) Fairly Priced After Recent Share Price Rebound?
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Wondering if DiaSorin at �...
Diasorin SpA (DSRLF) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Global ...
This article first appeared on GuruFocus. Revenue: EUR1.2 billion, a 1% increase compared to the previous year. Core Business Growth: 5% growth excluding COVID and at constant exchange rate. Adjusted...
Earnings To Watch: Diasorin SpA (MIL:DIA) Reports Q4 2025 Result
This article first appeared on GuruFocus. Diasorin SpA (MIL:DIA) is set to release its Q4 2025 earnings on March 20, 2026. The consensus estimate for Q4 2025 revenue is $0.30 billion, and the earning...
Diasorin SpA (FRA:34D) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst Market Challenges
This article first appeared on GuruFocus. Year-to-Date Revenue: 900 million, reflecting a 3% increase compared to the same period last year. COVID Sales Impact: $11 million reduction in COVID sales. ...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.